Valuation : IDEXX Laboratories, Inc.

Market Cap 39.9B 34.32B 32.38B 29.5B 55.14B 3,815B 55.64B 386B 148B 1,935B 150B 147B 6,147B P/E 2026 *
34.3x
P/E 2027 * 30.3x
Enterprise Value 40.27B 34.63B 32.68B 29.77B 55.65B 3,850B 56.16B 389B 150B 1,953B 151B 148B 6,203B EV / Sales 2026 *
8.52x
EV / Sales 2027 * 7.74x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -

Last Transcript : IDEXX Laboratories, Inc.

1 day-0.91%
1 week-6.21%
Current month-9.80%
1 month-14.40%
3 months-9.99%
6 months-16.38%
Current year-25.77%
1 week 500.61
Extreme 500.61
529.02
1 month 500.61
Extreme 500.61
584.15
Current year 500.61
Extreme 500.61
726.41
1 year 500.61
Extreme 500.61
769.98
3 years 356.14
Extreme 356.14
769.98
5 years 317.06
Extreme 317.06
769.98
10 years 102.45
Extreme 102.45
769.98
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Date Insider Type Main position Quantity % Market Cap. Importance
9/4/26 Exercice

Director

6,609 0.0084%
8/20/26 Exercice

Chief Financial Officer

616 0.0008%
7/30/26 Free

Director

49 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.91%-6.21%-22.17%+6.50% 39.9B
Average -0.91%-4.42%-22.17%+6.50% 39.9B
Weighted average by Cap. -0.91%-4.42%-22.17%+6.50%

Financials

2026 *2027 *
Net sales 4.72B 4.06B 3.83B 3.49B 6.53B 452B 6.59B 45.65B 17.57B 229B 17.74B 17.35B 728B 5.14B 4.42B 4.17B 3.8B 7.1B 491B 7.17B 49.67B 19.12B 249B 19.3B 18.88B 792B
Net income 1.18B 1.01B 956M 871M 1.63B 113B 1.64B 11.39B 4.38B 57.16B 4.43B 4.33B 182B 1.31B 1.13B 1.07B 972M 1.82B 126B 1.83B 12.7B 4.89B 63.74B 4.94B 4.83B 202B
Net Debt 368M 316M 299M 272M 509M 35.18B 513M 3.56B 1.37B 17.85B 1.38B 1.35B 56.68B -97.34M -83.71M -78.98M -71.95M -135M -9.31B -136M -941M -362M -4.72B -366M -358M -14.99B
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-09-11 $502.16 -0.86% 72,214
26-09-10 $506.53 -1.67% 422,340
26-09-09 $515.15 -0.97% 556,503
26-09-08 $520.21 -2.83% 613,034
26-09-04 $535.38 +1.15% 407,845
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
506.53USD
Average target price
698.92USD
Spread / Average Target
+37.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDXX Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!